Furthermore, both Breg subsets from tumor-bearing mice treated with Rat IgG, but not those treated with GSK, showed stronger inhibition on IFNγ production by CD4 T cells than the Breg counterparts from naïve mice (Fig. 3h). Here, CD4 is linked to neoplasm.